FDA: Opioid Medication Labels Will Include More Information on Appropriate Tapering in Physically Dependent Patients

The Food and Drug Administration is requiring labeling changes for all opioid analgesics used in the outpatient setting, to provide additional guidance on safe opioid tapering. The changes will provide more information on how to safely decrease the dose in opioid-dependent patients. However, as the agency noted in a press release, “there is no standard…

Next post in Opioid Addiction